; and (B) that were paid before such period began for registrations described in section 738(a)(3), but with respect to which a remitter has not been identified. (2) Subsequently received submission or registration Notwithstanding the obligation or expenditure of a fee for the process for the review of device applications pursuant to paragraph (1), such fee shall be deemed to have been paid for purposes of section 738(f)(1) if the Secretary subsequently receives a submission or registration for such fee. (c) Effect of enactment of subsequent appropriations Upon the enactment of an appropriation for fees under section 738 for a fiscal year, or a general appropriation bill providing appropriations for the Food and Drug Administration for a fiscal year without provision for such device fees, following a period during which a collection, obligation, or expenditure of fees occurs pursuant to subsection (a) or (b) for such fiscal year— (1) such collection, obligation, and expenditure shall be charged to such appropriation (if any); and (2) amounts made available pursuant to such subsection shall not be available after the date of the enactment of such appropriation or general appropriation bill. .